| Revealing the clinical impact of MTOR and ARID2 gene mutations on MALT lymphoma of the alimentary canal using targeted sequencing. | Revealing the clinical impact of MTOR and ARID2 gene mutations on MALT lymphoma of the alimentary canal using targeted sequencing.
Huang X, Zeng J, Luo Y, Luo S, Li Y, Wang J., Free PMC Article | 08/29/2024 |
| ARID2, a milder cause of Coffin-Siris Syndrome? Broadening the phenotype with 17 additional individuals. | ARID2, a milder cause of Coffin-Siris Syndrome? Broadening the phenotype with 17 additional individuals.
Schrier Vergano SA. | 05/3/2024 |
| ARID2 mutations may relay a distinct subset of cutaneous melanoma patients with different outcomes. | ARID2 mutations may relay a distinct subset of cutaneous melanoma patients with different outcomes.
Akinjiyan FA, Nassief G, Phillipps J, Adeyelu T, Elliott A, Abdulla F, Zhou AY, Souroullas G, Kim KB, Vanderwalde A, Park SJ, Ansstas G., Free PMC Article | 02/16/2024 |
| Coffin-Siris Syndrome: Case Series of Three Patients and a Novel ARID2 Variant. | Coffin-Siris Syndrome: Case Series of Three Patients and a Novel ARID2 Variant.
Shin D, Lee YJ, Jo YH, Kong J, Lee YJ, Nam SO, Lee BL, Oh SH, Kim YM. | 01/30/2024 |
| miR-29a-5p regulates the malignant biological process of liver cancer cells through ARID2 regulation of EMT. | miR-29a-5p regulates the malignant biological process of liver cancer cells through ARID2 regulation of EMT.
Li W, Jiang Y, Pan Q, Yang G. | 05/30/2023 |
| ARID2, a rare cause of Coffin-Siris syndrome: A novel microdeletion at 12q12q13.11 causing severe short stature and literature review. | ARID2, a rare cause of Coffin-Siris syndrome: A novel microdeletion at 12q12q13.11 causing severe short stature and literature review.
Xia D, Deng S, Gao C, Li X, Zhang L, Xiao X, Peng X, Zhang J, He Z, Meng Z, Liu Z, Ouyang N, Liang L. | 04/12/2023 |
| USP2 Inhibits Lung Cancer Pathogenesis by Reducing ARID2 Protein Degradation via Ubiquitination. | USP2 Inhibits Lung Cancer Pathogenesis by Reducing ARID2 Protein Degradation via Ubiquitination.
Zhu L, Chen Z, Guo T, Chen W, Zhao L, Guo L, Pan X., Free PMC Article | 01/14/2023 |
| ARID2 suppression promotes tumor progression and upregulates cytokeratin 8, 18 and beta-4 integrin expression in TP53-mutated tobacco-related oral cancer and has prognostic implications. | ARID2 suppression promotes tumor progression and upregulates cytokeratin 8, 18 and β-4 integrin expression in TP53-mutated tobacco-related oral cancer and has prognostic implications.
Shukla P, Dange P, Mohanty BS, Gadewal N, Chaudhari P, Sarin R. | 12/24/2022 |
| Altered BAF occupancy and transcription factor dynamics in PBAF-deficient melanoma. | Altered BAF occupancy and transcription factor dynamics in PBAF-deficient melanoma.
Carcamo S, Nguyen CB, Grossi E, Filipescu D, Alpsoy A, Dhiman A, Sun D, Narang S, Imig J, Martin TC, Parsons R, Aifantis I, Tsirigos A, Aguirre-Ghiso JA, Dykhuizen EC, Hasson D, Bernstein E., Free PMC Article | 04/23/2022 |
| BRD4 inhibition induces synthetic lethality in ARID2-deficient hepatocellular carcinoma by increasing DNA damage. | BRD4 inhibition induces synthetic lethality in ARID2-deficient hepatocellular carcinoma by increasing DNA damage.
He DD, Shang XY, Wang N, Wang GX, He KY, Wang L, Han ZG. | 04/23/2022 |
| Association between ARID2 and RAS-MAPK pathway in intellectual disability and short stature. | Association between ARID2 and RAS-MAPK pathway in intellectual disability and short stature.
Kang E, Kang M, Ju Y, Lee SJ, Lee YS, Woo DC, Sung YH, Baek IJ, Shim WH, Son WC, Choi IH, Seo EJ, Yoo HW, Han YM, Lee BH. | 02/26/2022 |
| ARID2 Deficiency Correlates with the Response to Immune Checkpoint Blockade in Melanoma. | ARID2 Deficiency Correlates with the Response to Immune Checkpoint Blockade in Melanoma.
Fukumoto T, Lin J, Fatkhutdinov N, Liu P, Somasundaram R, Herlyn M, Zhang R, Nishigori C. | 11/22/2021 |
| CREB1 acts via the miR922/ARID2 axis to enhance malignant behavior of liver cancer cells. | CREB1 acts via the miR‑922/ARID2 axis to enhance malignant behavior of liver cancer cells.
Liu X, Zhang H, Zhou P, Yu Y, Zhang H, Chen L, Gong J, Liu Z., Free PMC Article | 11/13/2021 |
| ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer. | ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer.
Moreno T, Monterde B, González-Silva L, Betancor-Fernández I, Revilla C, Agraz-Doblas A, Freire J, Isidro P, Quevedo L, Blanco R, Montes-Moreno S, Cereceda L, Astudillo A, Casar B, Crespo P, Morales Torres C, Scaffidi P, Gómez-Román J, Salido E, Varela I., Free PMC Article | 11/6/2021 |
| ARID1A, ARID1B, and ARID2 Mutations Serve as Potential Biomarkers for Immune Checkpoint Blockade in Patients With Non-Small Cell Lung Cancer. | ARID1A, ARID1B, and ARID2 Mutations Serve as Potential Biomarkers for Immune Checkpoint Blockade in Patients With Non-Small Cell Lung Cancer.
Zhu G, Shi R, Li Y, Zhang Z, Xu S, Chen C, Cao P, Zhang H, Liu M, Pan Z, Liu H, Chen J., Free PMC Article | 10/23/2021 |
| Exome sequencing identifies ARID2 as a novel tumor suppressor in early-onset sporadic rectal cancer. | Exome sequencing identifies ARID2 as a novel tumor suppressor in early-onset sporadic rectal cancer.
Bala P, Singh AK, Kavadipula P, Kotapalli V, Sabarinathan R, Bashyam MD. | 07/31/2021 |
| Expression and prognostic values of ARID family members in breast cancer. | Expression and prognostic values of ARID family members in breast cancer.
Zhang J, Hou S, You Z, Li G, Xu S, Li X, Zhang X, Lei B, Pang D., Free PMC Article | 07/24/2021 |
| Long non-coding RNA Arid2-IR affects advanced glycation end products-induced human retinal endothelial cell injury by binding to Smad3. | Long non-coding RNA Arid2-IR affects advanced glycation end products-induced human retinal endothelial cell injury by binding to Smad3.
Xiao H, Yang H, Zeng Y. | 03/27/2021 |
| MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2. | MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2.
Wu M, Duan Q, Liu X, Zhang P, Fu Y, Zhang Z, Liu L, Cheng J, Jiang H. | 10/3/2020 |
| The binding between HBc and BAF200 was of vital importance to HBc mediated downregulation of interferon-induced transmembrane protein 1 (IFITM1) expression. | Human Hepatitis B Virus Core Protein Inhibits IFNα-Induced IFITM1 Expression by Interacting with BAF200.
Li T, Ke Z, Liu W, Xiong Y, Zhu Y, Liu Y., Free PMC Article | 07/25/2020 |
| Mutations in or involving the ARID2 gene were identified in the patients with the features resembling Coffin-Siris syndrome. | Extending the clinical and genetic spectrum of ARID2 related intellectual disability. A case series of 7 patients.
Gazdagh G, Blyth M, Scurr I, Turnpenny PD, Mehta SG, Armstrong R, McEntagart M, Newbury-Ecob R, Tobias ES, DDD Study, Joss S. | 03/9/2019 |
| We present a 4-year-old girl with delayed neuromotor development, short stature of prenatal onset, and specific behavioral and craniofacial features harboring an intragenic deletion in the ARID2 gene. The phenotype confirmed the major features of the recently described ARID2-related intellectual disability syndrome. | Confirmation of an ARID2 defect in SWI/SNF-related intellectual disability.
Van Paemel R, De Bruyne P, van der Straaten S, D'hondt M, Fränkel U, Dheedene A, Menten B, Callewaert B. | 06/9/2018 |
| These findings highlight the potential role of ARID2 as a tumor growth suppressor in hepatocellular carcinoma | Chromatin remodeling gene ARID2 targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression.
Duan Y, Tian L, Gao Q, Liang L, Zhang W, Yang Y, Zheng Y, Pan E, Li S, Tang N., Free PMC Article | 01/13/2018 |
| ARID2 knockout could contribute to disruption of DNA repair process. | ARID2 modulates DNA damage response in human hepatocellular carcinoma cells.
Oba A, Shimada S, Akiyama Y, Nishikawaji T, Mogushi K, Ito H, Matsumura S, Aihara A, Mitsunori Y, Ban D, Ochiai T, Kudo A, Asahara H, Kaida A, Miura M, Tanabe M, Tanaka S. | 10/28/2017 |
| study identifies mutations in the ARID2 gene as a novel and rare cause for a CSS-like phenotype and enlarges the list of CSS-like genes | Heterozygosity for ARID2 loss-of-function mutations in individuals with a Coffin-Siris syndrome-like phenotype.
Bramswig NC, Caluseriu O, Lüdecke HJ, Bolduc FV, Noel NC, Wieland T, Surowy HM, Christen HJ, Engels H, Strom TM, Wieczorek D. | 06/24/2017 |